469 related articles for article (PubMed ID: 18036648)
1. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.
Schroeder JT; Chichester KL; Bieneman AP
J Allergy Clin Immunol; 2008 Feb; 121(2):486-91. PubMed ID: 18036648
[TBL] [Abstract][Full Text] [Related]
2. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.
Martinelli E; Cicala C; Van Ryk D; Goode DJ; Macleod K; Arthos J; Fauci AS
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3396-401. PubMed ID: 17360657
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells.
Lund J; Sato A; Akira S; Medzhitov R; Iwasaki A
J Exp Med; 2003 Aug; 198(3):513-20. PubMed ID: 12900525
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-mediated inhibition of TLR9-dependent IFN-α induction in plasmacytoid dendritic cells questions bacterial DNA as the active ingredient of bacterial lysates.
Poth JM; Coch C; Busch N; Boehm O; Schlee M; Janke M; Zillinger T; Schildgen O; Barchet W; Hartmann G
J Immunol; 2010 Dec; 185(12):7367-73. PubMed ID: 21057083
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
8. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
Guiducci C; Ott G; Chan JH; Damon E; Calacsan C; Matray T; Lee KD; Coffman RL; Barrat FJ
J Exp Med; 2006 Aug; 203(8):1999-2008. PubMed ID: 16864658
[TBL] [Abstract][Full Text] [Related]
9. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
Marshall JD; Heeke DS; Abbate C; Yee P; Van Nest G
Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
11. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9.
Tversky JR; Le TV; Bieneman AP; Chichester KL; Hamilton RG; Schroeder JT
Clin Exp Allergy; 2008 May; 38(5):781-8. PubMed ID: 18318750
[TBL] [Abstract][Full Text] [Related]
12. Interferons modulate Fc epsilon RI-dependent production of autoregulatory IL-10 by circulating human monocytoid dendritic cells.
Le T; Tversky J; Chichester KL; Bieneman AP; Huang SK; Wood RA; Schroeder JT
J Allergy Clin Immunol; 2009 Jan; 123(1):217-23. PubMed ID: 18845324
[TBL] [Abstract][Full Text] [Related]
13. Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance.
Berghöfer B; Frommer T; König IR; Ziegler A; Chakraborty T; Bein G; Hackstein H
Clin Exp Allergy; 2005 Sep; 35(9):1147-54. PubMed ID: 16164440
[TBL] [Abstract][Full Text] [Related]
14. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
[TBL] [Abstract][Full Text] [Related]
15. TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells.
Fiola S; Gosselin D; Takada K; Gosselin J
J Immunol; 2010 Sep; 185(6):3620-31. PubMed ID: 20713890
[TBL] [Abstract][Full Text] [Related]
16. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC.
Meyers JA; Mangini AJ; Nagai T; Roff CF; Sehy D; van Seventer GA; van Seventer JM
Cytokine; 2006 Sep; 35(5-6):235-46. PubMed ID: 17052915
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.
Honda K; Ohba Y; Yanai H; Negishi H; Mizutani T; Takaoka A; Taya C; Taniguchi T
Nature; 2005 Apr; 434(7036):1035-40. PubMed ID: 15815647
[TBL] [Abstract][Full Text] [Related]
18. Impaired IFN-α secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria.
Futata E; Azor M; Dos Santos J; Maruta C; Sotto M; Guedes F; Rivitti E; Duarte A; Sato M
Br J Dermatol; 2011 Jun; 164(6):1271-9. PubMed ID: 21198536
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G
Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840
[TBL] [Abstract][Full Text] [Related]
20. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
